Westmount Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Westmount Partners's MRK Position: Q2 2026 in Review
Westmount Partners increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $14.4K and bringing the position to 5,013 shares worth $644K. The position accounts for 0.14% of the portfolio, ranked #120.
Westmount Partners first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $735K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Westmount Partners held 5,013 shares of Merck worth $644K as of Q2 2026.
- Westmount Partners bought 123 Merck shares in Q2 2026, an estimated $14.4K.
- Merck made up 0.14% of Westmount Partners's portfolio in Q2 2026, its #120 holding.
- Westmount Partners first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
- Westmount Partners's Merck position peaked at $735K in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Westmount Partners's 13F filing for Q2 2026, filed 7 Jul 2026.